Cryo-EM structures of human RNA polymerase III in its unbound and transcribing states.


Journal

Nature structural & molecular biology
ISSN: 1545-9985
Titre abrégé: Nat Struct Mol Biol
Pays: United States
ID NLM: 101186374

Informations de publication

Date de publication:
02 2021
Historique:
received: 27 06 2020
accepted: 21 12 2020
pubmed: 10 2 2021
medline: 1 4 2021
entrez: 9 2 2021
Statut: ppublish

Résumé

RNA polymerase III (Pol III) synthesizes transfer RNAs and other short, essential RNAs. Human Pol III misregulation is linked to tumor transformation, neurodegenerative and developmental disorders, and increased sensitivity to viral infections. Here, we present cryo-electron microscopy structures at 2.8 to 3.3 Å resolution of transcribing and unbound human Pol III. We observe insertion of the TFIIS-like subunit RPC10 into the polymerase funnel, providing insights into how RPC10 triggers transcription termination. Our structures resolve elements absent from Saccharomyces cerevisiae Pol III such as the winged-helix domains of RPC5 and an iron-sulfur cluster, which tethers the heterotrimer subcomplex to the core. The cancer-associated RPC7α isoform binds the polymerase clamp, potentially interfering with Pol III inhibition by tumor suppressor MAF1, which may explain why overexpressed RPC7α enhances tumor transformation. Finally, the human Pol III structure allows mapping of disease-related mutations and may contribute to the development of inhibitors that selectively target Pol III for therapeutic interventions.

Identifiants

pubmed: 33558764
doi: 10.1038/s41594-020-00555-5
pii: 10.1038/s41594-020-00555-5
pmc: PMC7610652
mid: EMS114681
doi:

Substances chimiques

RNA Polymerase III EC 2.7.7.6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

210-219

Commentaires et corrections

Type : CommentIn

Références

Arimbasseri, A. G. & Maraia, R. J. RNA polymerase III advances: structural and tRNA functional views. Trends Biochem. Sci. 41, 546–559 (2016).
pubmed: 27068803 pmcid: 4884153 doi: 10.1016/j.tibs.2016.03.003
Willis, I. M. & Moir, R. D. Signaling to and from the RNA polymerase III transcription and processing machinery. Annu. Rev. Biochem. 87, 75–100 (2018).
pubmed: 29328783 pmcid: 6038698 doi: 10.1146/annurev-biochem-062917-012624
Lei, J., Chen, S. & Zhong, S. Abnormal expression of TFIIIB subunits and RNA Pol III genes is associated with hepatocellular carcinoma. Liver Res. 1, 112–120 (2017).
pubmed: 29276645 pmcid: 5739085 doi: 10.1016/j.livres.2017.08.005
Petrie, J. L. et al. Effects on prostate cancer cells of targeting RNA polymerase III. Nucleic Acids Res. 47, 3937–3956 (2019).
pubmed: 30820548 pmcid: 6486637 doi: 10.1093/nar/gkz128
Filer, D. et al. RNA polymerase III limits longevity downstream of TORC1. Nature 552, 263–267 (2017).
pubmed: 29186112 pmcid: 5732570 doi: 10.1038/nature25007
Ablasser, A. et al. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat. Immunol. 10, 1065–1072 (2009).
pubmed: 19609254 doi: 10.1038/ni.1779
Chiu, Y.-H., MacMillan, J. B. & Chen, Z. J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138, 576–591 (2009).
pubmed: 19631370 pmcid: 2747301 doi: 10.1016/j.cell.2009.06.015
Bernard, G. et al. Mutations of POLR3A encoding a catalytic subunit of RNA polymerase Pol III cause a recessive hypomyelinating leukodystrophy. Am. J. Hum. Genet. 89, 415–423 (2011).
pubmed: 21855841 pmcid: 3169829 doi: 10.1016/j.ajhg.2011.07.014
Tétreault, M. et al. Recessive mutations in POLR3B, encoding the second largest subunit of Pol III, cause a rare hypomyelinating leukodystrophy. Am. J. Hum. Genet. 89, 652–655 (2011).
pubmed: 22036172 pmcid: 3213403 doi: 10.1016/j.ajhg.2011.10.006
Thiffault, I. et al. Recessive mutations in POLR1C cause a leukodystrophy by impairing biogenesis of RNA polymerase III. Nat. Commun. 6, 7623 (2015).
pubmed: 26151409 doi: 10.1038/ncomms8623
Saitsu, H. et al. Mutations in POLR3A and POLR3B encoding RNA polymerase III subunits cause an autosomal-recessive hypomyelinating leukoencephalopathy. Am. J. Hum. Genet. 89, 644–651 (2011).
pubmed: 22036171 pmcid: 3213392 doi: 10.1016/j.ajhg.2011.10.003
Gauquelin, L. et al. Clinical spectrum of POLR3-related leukodystrophy caused by biallelic POLR1C pathogenic variants. Neurol. Genet. 5, e369 (2019).
pubmed: 32042905 pmcid: 6927361 doi: 10.1212/NXG.0000000000000369
Wolf, N. I. et al. Clinical spectrum of 4H leukodystrophy caused by POLR3A and POLR3B mutations. Neurology 83, 1898–1905 (2014).
pubmed: 25339210 pmcid: 4248461 doi: 10.1212/WNL.0000000000001002
Dorboz, I. et al. Mutation in POLR3K causes hypomyelinating leukodystrophy and abnormal ribosomal RNA regulation. Neurol. Genet. 4, e289 (2018).
pubmed: 30584594 pmcid: 6283457 doi: 10.1212/NXG.0000000000000289
Paolacci, S. et al. Specific combinations of biallelic POLR3A variants cause Wiedemann–Rautenstrauch syndrome. J. Med. Genet. 55, 837–846 (2018).
pubmed: 30323018 doi: 10.1136/jmedgenet-2018-105528
Wambach, J. A. et al. Bi-allelic POLR3A loss-of-function variants cause autosomal-recessive Wiedemann–Rautenstrauch syndrome. Am. J. Hum. Genet. 103, 968–975 (2018).
pubmed: 30414627 pmcid: 6288318 doi: 10.1016/j.ajhg.2018.10.010
Dauwerse, J. G. et al. Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome. Nat. Genet. 43, 20–22 (2011).
pubmed: 21131976 doi: 10.1038/ng.724
Ogunjimi, B. et al. Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections. J. Clin. Invest. 127, 3543–3556 (2017).
pubmed: 28783042 pmcid: 5669568 doi: 10.1172/JCI92280
Carter-Timofte, M. E. et al. Mutations in RNA Polymerase III genes and defective DNA sensing in adults with varicella-zoster virus CNS infection. Genes Immun. 127, 3543–3556 (2017).
Vannini, A. & Cramer, P. Conservation between the RNA polymerase I, II, and III transcription initiation machineries. Mol. Cell 45, 439–446 (2012).
pubmed: 22365827 doi: 10.1016/j.molcel.2012.01.023
Brun, I., Sentenac, A. & Werner, M. Dual role of the C34 subunit of RNA polymerase III in transcription initiation. EMBO J. 16, 5730–5741 (1997).
pubmed: 9312031 pmcid: 1170204 doi: 10.1093/emboj/16.18.5730
Wang, Z. & Roeder, R. G. Three human RNA polymerase III-specific subunits form a subcomplex with a selective function in specific transcription initiation. Genes Dev. 11, 1315–1326 (1997).
pubmed: 9171375 doi: 10.1101/gad.11.10.1315
Lefèvre, S. et al. Structure-function analysis of hRPC62 provides insights into RNA polymerase III transcription initiation. Nat. Struct. Mol. Biol. 18, 352–358 (2011).
pubmed: 21358628 doi: 10.1038/nsmb.1996
Hu, P. et al. Characterization of human RNA polymerase III identifies orthologues for Saccharomyces cerevisiae RNA polymerase III subunits. Mol. Cell. Biol. 22, 8044–8055 (2002).
pubmed: 12391170 pmcid: 134740 doi: 10.1128/MCB.22.22.8044-8055.2002
Kassavetis, G. A., Prakash, P. & Shim, E. The C53/C37 subcomplex of RNA polymerase III lies near the active site and participates in promoter opening. J. Biol. Chem. 285, 2695–2706 (2010).
pubmed: 19940126 doi: 10.1074/jbc.M109.074013
Arimbasseri, A. G. & Maraia, R. J. Mechanism of transcription termination by RNA polymerase III utilizes a non-template strand sequence-specific signal element. Mol. Cell 58, 1124–1132 (2015).
pubmed: 25959395 pmcid: 4475470 doi: 10.1016/j.molcel.2015.04.002
Landrieux, E. et al. A subcomplex of RNA polymerase III subunits involved in transcription termination and reinitiation. EMBO J. 25, 118–128 (2006).
pubmed: 16362040 doi: 10.1038/sj.emboj.7600915
Chédin, S., Riva, M., Schultz, P., Sentenac, A. & Caries, C. The RNA cleavage activity of RNA polymerase III is mediated by an essential TFIIS-like subunit and is important for transcription termination. Genes Dev. 12, 3857–3871 (1998).
pubmed: 9869639 pmcid: 317263 doi: 10.1101/gad.12.24.3857
Iben, J. R. et al. Point mutations in the Rpb9-homologous domain of Rpc11 that impair transcription termination by RNA polymerase III. Nucleic Acids Res. 39, 6100–6113 (2011).
pubmed: 21450810 pmcid: 3152337 doi: 10.1093/nar/gkr182
Blombach, F. et al. Archaeal TFEα/β is a hybrid of TFIIE and the RNA polymerase III subcomplex hRPC62/39. Elife 4, e08378 (2015).
pubmed: 26067235 pmcid: 4495717 doi: 10.7554/eLife.08378
Haurie, V. et al. Two isoforms of human RNA polymerase III with specific functions in cell growth and transformation. Proc. Natl Acad. Sci. USA 107, 4176–4181 (2010).
pubmed: 20154270 pmcid: 2840155 doi: 10.1073/pnas.0914980107
Hoffmann, N. A. et al. Molecular structures of unbound and transcribing RNA polymerase III. Nature 528, 231–236 (2015).
pubmed: 26605533 pmcid: 4681132 doi: 10.1038/nature16143
Abascal-Palacios, G., Ramsay, E. P., Beuron, F., Morris, E. & Vannini, A. Structural basis of RNA polymerase III transcription initiation. Nature 553, 301–306 (2018).
pubmed: 29345637 doi: 10.1038/nature25441
Vorländer, M. K., Khatter, H., Wetzel, R., Hagen, W. J. H. & Müller, C. W. Molecular mechanism of promoter opening by RNA polymerase III. Nature 553, 295–300 (2018).
pubmed: 29345638 pmcid: 5777638 doi: 10.1038/nature25440
Han, Y., Yan, C., Fishbain, S., Ivanov, I. & He, Y. Structural visualization of RNA polymerase III transcription machineries. Cell Discov. 4, 40 (2018).
pubmed: 30083386 pmcid: 6066478 doi: 10.1038/s41421-018-0044-z
Vorländer, M. K. et al. Structural basis for RNA polymerase III transcription repression by Maf1. Nat. Struct. Mol. Biol. 27, 229–232 (2020).
pubmed: 32066962 pmcid: 7104376 doi: 10.1038/s41594-020-0383-y
Bernecky, C., Herzog, F., Baumeister, W., Plitzko, J. M. & Cramer, P. Structure of transcribing mammalian RNA polymerase II. Nature 529, 551–554 (2016).
pubmed: 26789250 doi: 10.1038/nature16482
Kettenberger, H., Armache, K. J. & Cramer, P. Complete RNA polymerase II elongation complex structure and its interactions with NTP and TFIIS. Mol. Cell 16, 955–965 (2004).
pubmed: 15610738 doi: 10.1016/j.molcel.2004.11.040
Wang, D. et al. Structural basis of transcription: backtracked RNA polymerase II at 3.4 Angstrom resolution. Science 324, 1203–1206 (2009).
pubmed: 19478184 pmcid: 2718261 doi: 10.1126/science.1168729
Cheung, A. C. M. & Cramer, P. Structural basis of RNA polymerase II backtracking, arrest and reactivation. Nature 471, 249–253 (2011).
pubmed: 21346759 doi: 10.1038/nature09785
Punjani, A. & Fleet, D. J. 3D variability analysis: resolving continuous flexibility and discrete heterogeneity from single particle cryo-EM. Preprint at bioRxiv https://doi.org/10.1101/2020.04.08.032466 (2020).
Huang, Y., Intine, R. V., Mozlin, A., Hasson, S. & Maraia, R. J. Mutations in the RNA Polymerase III subunit Rpc11p that decrease RNA 3′ cleavage activity increase 3′-terminal oligo(U) length and La-dependent tRNA processing. Mol. Cell. Biol. 25, 621–636 (2005).
pubmed: 15632064 pmcid: 543423 doi: 10.1128/MCB.25.2.621-636.2005
Mishra, S. & Maraia, R. J. RNA polymerase III subunits C37/53 modulate rU:dA hybrid 3′ end dynamics during transcription termination. Nucleic Acids Res. 47, 310–327 (2019).
pubmed: 30407541 doi: 10.1093/nar/gky1109
Dieci, G. & Sentenac, A. Facilitated recycling pathway for RNA polymerase III. Cell 84, 245–252 (1996).
pubmed: 8565070 doi: 10.1016/S0092-8674(00)80979-4
He, Y. et al. Near-atomic resolution visualization of human transcription promoter opening. Nature 533, 359–365 (2016).
pubmed: 27193682 pmcid: 4940141 doi: 10.1038/nature17970
Wang, Z., Wu, C., Aslanian, A., Yates, J. R. & Hunter, T. Defective RNA polymerase III is negatively regulated by the SUMO-Ubiquitin-Cdc48 pathway. Elife 7, e35447 (2018).
pubmed: 30192228 pmcid: 6128692 doi: 10.7554/eLife.35447
Sadian, Y. et al. Molecular insight into RNA polymerase I promoter recognition and promoter melting. Nat. Commun. 10, 5543 (2019).
pubmed: 31804486 pmcid: 6895186 doi: 10.1038/s41467-019-13510-w
Dergai, O. & Hernandez, N. How to recruit the correct RNA polymerase? Lessons from snRNA genes. Trends Genet. 35, 457–469 (2019).
pubmed: 31040056 doi: 10.1016/j.tig.2019.04.001
Renaud, M. et al. Gene duplication and neofunctionalization: POLR3G and POLR3GL. Genome Res. 24, 37–51 (2014).
pubmed: 24107381 pmcid: 3875860 doi: 10.1101/gr.161570.113
Durrieu-Gaillard, S. et al. Regulation of RNA polymerase III transcription during transformation of human IMR90 fibroblasts with defined genetic elements. Cell Cycle 17, 605–615 (2018).
pubmed: 29171785 pmcid: 5969553 doi: 10.1080/15384101.2017.1405881
Davis, R. B., Likhite, N., Jackson, C. A., Liu, T. & Yu, M. C. Robust repression of tRNA gene transcription during stress requires protein arginine methylation. Life Sci. Alliance 2, e201800261 (2019).
pubmed: 31160378 pmcid: 6549136 doi: 10.26508/lsa.201800261
Maraia, R. J. & Rijal, K. A transcriptional specialist resolved. Nature 528, 204–205 (2015).
pubmed: 26605522 pmcid: 5443343 doi: 10.1038/nature16317
Koch, B. et al. Generation and validation of homozygous fluorescent knock-in cells using CRISPR–Cas9 genome editing. Nat. Protoc. 13, 1465–1487 (2018).
pubmed: 29844520 pmcid: 6556379 doi: 10.1038/nprot.2018.042
Ran, F. A. et al. Genome engineering using the CRISPR–Cas9 system. Nat. Protoc. 8, 2281–2308 (2013).
pubmed: 24157548 pmcid: 3969860 doi: 10.1038/nprot.2013.143
Lin, Y. C. et al. Genome dynamics of the human embryonic kidney 293 lineage in response to cell biology manipulations. Nat. Commun. 5, 4767 (2014).
pubmed: 25182477 doi: 10.1038/ncomms5767
Kim, J. H. et al. High cleavage efficiency of a 2A peptide derived from porcine Teschovirus-1 in human cell lines, zebrafish and mice. PLoS ONE 6, e18556 (2011).
pubmed: 21602908 pmcid: 3084703 doi: 10.1371/journal.pone.0018556
Moreno-Morcillo, M. et al. Solving the RNA polymerase I structural puzzle. Acta Crystallogr. D Biol. Crystallogr. 70, 2570–2582 (2014).
pubmed: 25286842 pmcid: 4188003 doi: 10.1107/S1399004714015788
Federhen, S. The NCBI Taxonomy Database. Nucleic Acids Res. 40, D136–D143 (2012).
pubmed: 22139910 doi: 10.1093/nar/gkr1178
The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 47, D506–D515 (2019).
doi: 10.1093/nar/gky1049
Eddy, S. R. Accelerated profile HMM searches. PLoS Comput. Biol. 7, e1002195 (2011).
pubmed: 22039361 pmcid: 3197634 doi: 10.1371/journal.pcbi.1002195
El-Gebali, S. et al. The Pfam protein families database in 2019. Nucleic Acids Res. 47, D427–D432 (2019).
pubmed: 30357350 doi: 10.1093/nar/gky995
Letunic, I. & Bork, P. Interactive Tree Of Life (iTOL) v4: recent updates and new developments. Nucleic Acids Res. 47, W256–W259 (2019).
pubmed: 30931475 pmcid: 6602468 doi: 10.1093/nar/gkz239
Kayikci, M. et al. Visualization and analysis of non-covalent contacts using the Protein Contacts Atlas. Nat. Struct. Mol. Biol. 25, 185–194 (2018).
pubmed: 29335563 pmcid: 5837000 doi: 10.1038/s41594-017-0019-z
Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).
pubmed: 14597658 pmcid: 403769 doi: 10.1101/gr.1239303
Csárdi, G. & Nepusz, T. The igraph software package for complex network research. Inter. J. Comp. Syst. 1695, 1–9 (2006).
Mitternacht, S. FreeSASA: an open source C library for solvent accessible surface area calculations. F1000 Res. 5, 189 (2016).
doi: 10.12688/f1000research.7931.1
Nakane, T., Kimanius, D., Lindahl, E. & Scheres, S. H. W. Characterisation of molecular motions in cryo-EM single-particle data by multi-body refinement in RELION. Elife 7, e36861 (2018).
pubmed: 29856314 pmcid: 6005684 doi: 10.7554/eLife.36861
Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife 7, e42166 (2018).
pubmed: 30412051 pmcid: 6250425 doi: 10.7554/eLife.42166
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
pubmed: 28165473 doi: 10.1038/nmeth.4169
Hwang, S., Gou, Z. & Kuznetsov, I. B. DP-Bind: a web server for sequence-based prediction of DNA-binding residues in DNA-binding proteins. Bioinformatics 23, 634–636 (2007).
pubmed: 17237068 doi: 10.1093/bioinformatics/btl672
Hornbeck, P. V. et al. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res. 43, D512–D520 (2015).
pubmed: 25514926 doi: 10.1093/nar/gku1267
Zimmermann, L. et al. A completely reimplemented MPI bioinformatics toolkit with a new HHpred server at its core. J. Mol. Biol. 430, 2237–2243 (2018).
pubmed: 29258817 doi: 10.1016/j.jmb.2017.12.007
Kim, M. K. et al. Assembly of SNAPc, Bdp1, and TBP on the U6 snRNA gene promoter in Drosophila melanogaster. Mol. Cell. Biol. 40, e00641-19 (2020).
pubmed: 32253345 pmcid: 7261721 doi: 10.1128/MCB.00641-19
Notredame, C., Higgins, D. G. & Heringa, J. T-coffee: a novel method for fast and accurate multiple sequence alignment. J. Mol. Biol. 302, 205–217 (2000).
pubmed: 10964570 doi: 10.1006/jmbi.2000.4042
Madeira, F. et al. The EMBL–EBI search and sequence analysis tools APIs in 2019. Nucleic Acids Res. 47, W636–W641 (2019).
pubmed: 30976793 pmcid: 6602479 doi: 10.1093/nar/gkz268

Auteurs

Mathias Girbig (M)

European Molecular Biology Laboratory (EMBL), Structural and Computational Biology Unit, Heidelberg, Germany.
Candidate for joint PhD degree from EMBL and Heidelberg University, Faculty of Biosciences, Heidelberg, Germany.

Agata D Misiaszek (AD)

European Molecular Biology Laboratory (EMBL), Structural and Computational Biology Unit, Heidelberg, Germany.
Candidate for joint PhD degree from EMBL and Heidelberg University, Faculty of Biosciences, Heidelberg, Germany.

Matthias K Vorländer (MK)

European Molecular Biology Laboratory (EMBL), Structural and Computational Biology Unit, Heidelberg, Germany.

Aleix Lafita (A)

European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, UK.

Helga Grötsch (H)

European Molecular Biology Laboratory (EMBL), Structural and Computational Biology Unit, Heidelberg, Germany.

Florence Baudin (F)

European Molecular Biology Laboratory (EMBL), Structural and Computational Biology Unit, Heidelberg, Germany.

Alex Bateman (A)

European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, UK.

Christoph W Müller (CW)

European Molecular Biology Laboratory (EMBL), Structural and Computational Biology Unit, Heidelberg, Germany. christoph.mueller@embl.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH